These features included PVs in BRCA1/BRCA2 for breast and ovarian cancer, PVs in TP53 for sarcoma, breast and other Li-Fraumeni-related cancers, or lobular breast cancer which is more common with CDH1 PVs. The gene discussed is BRCA2; the disease is ovarian carcinoma.